Kura Oncology (KURA) Institutional Ownership

Of the 184 institutional investors that purchased Kura Oncology's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BlackRock Inc. ($10.51M), BVF Inc. IL ($5.19M), RA Capital Management L.P. ($4.45M), Jacobs Levy Equity Management Inc. ($2.67M), Bank of America Corp DE ($1.72M), AQR Capital Management LLC ($1.61M), and State Street Corp ($1.59M).

Institutional investors have bought a total of 31,269,883 shares in the last 24 months. This purchase volume represents approximately $323.04M in transactions.

Of the 56 institutional investors that sold Kura Oncology's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Armistice Capital LLC ($1.53M), Millennium Management LLC ($1.04M), Assenagon Asset Management S.A. ($997.28K), Pale Fire Capital SE ($800.87K), Goldman Sachs Group Inc. ($777.46K), Prosight Management LP ($651.58K), and Sectoral Asset Management Inc. ($341.76K).

Institutional investors have sold a total of 9,560,379 shares in the last 24 months. This volume of shares sold represents approximately $91.39M in transactions.